Characterization of Glyoxal Modified LDL: Role in the Generation of Circulating Autoantibodies in Type 2 Diabetes Mellitus and Coronary Artery Disease

被引：0
作者：
Rizwee, Md Masum [1 ]
Abidi, Minhal [1 ]
Habib, Safia [1 ]
Mir, Abdul Rouf [1 ]
Ali, Asif [1 ]
Uddin, Moin [1 ]
机构：
[1] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Fac Med, Dept Biochem, Aligarh, Uttar Pradesh, India
来源：
CURRENT DRUG DELIVERY | 2021年 / 18卷 / 07期
关键词：
Glyoxal; LDL; Glycation; type 2 diabetes mellitus; coronary artery disease; autoimmunity; LOW-DENSITY-LIPOPROTEIN; GLYCATION END-PRODUCTS; METHYLGLYOXAL LEVELS; AUTOIMMUNE-RESPONSE; MODIFIED DNA; ANTIBODIES; PROTEIN; GLYCOXIDATION; CONSEQUENCES; OXIDATION;
D O I：
10.2174/1389450122666210114123959
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Aims: This study aims to investigate the role of glyoxal modified LDL in the immunopathology of diabetes and cardiovascular disease. Background: Glycoxidation of proteins is widely studied in relation to diabetes and cardiovascular disease. Objective: This study probed the glyoxal mediated modifications in LDL, analyzed the immunogenicity of the glycated LDL and ascertained the presence of circulating antibodies against modified LDL in patients with type 2 diabetes mellitus (T2DM), coronary artery disease (CAD) and patients with both (T2DM+CAD). Methods: Glyoxal mediated modifications in LDL were studied by multiple spectroscopic techniques, high-performance liquid chromatography and electron microscopy. Immunization studies were carried in New Zealand rabbits. The presence of antibodies against glyoxal modified LDL in immunized rabbits and human subjects was analyzed by ELISA. Results: Glyoxal altered the structural integrity of LDL and led to the formation of AGEs. It decreased the alpha-helix content of LDL; increased beta sheet formation, increased carbonyl content and decreased free lysine and arginine content. Modified LDL showed aggregation, generation of of N epsilon- (Carboxymethyl) lysine and the formation of amorphous type aggregates. It exhibited high antigenicity and generated a specific immune response that shared common antigenic determinants with other glycated proteins. Direct binding data showed the presence of anti-glyoxal modified LDL antibodies in patients with T2DM, CAD and patients with both T2DM and CAD. Further analysis in competitive binding assay revealed specific binding characteristics of auto-antibodies. Sera from patients with T2DM+CAD exhibited the highest binding with glyoxal modified LDL. Conclusion: Glyoxal-modified LDL has neo-antigenic determinants that cause the generation of circulating antibodies in diabetes and coronary artery disease. The study might have potential relevance in biomarker development.
引用
收藏
页码：1015 / 1028
页数：14
相关论文
共 61 条
[31]   The neoepitopes on methylglyoxal (MG) glycated LDL create autoimmune response; autoimmunity detection in T2DM patients with varying disease duration [J].
Khan, Mohd Yasir ;
Alouffi, Sultan ;
Khan, Mohd Shahnawaz ;
Husain, Fohad Mabood ;
Akhter, Firoz ;
Ahmad, Saheem .
CELLULAR IMMUNOLOGY, 2020, 351
[32]   Evaluation of glyoxal and methylglyoxal levels in uremic patients under peritoneal dialysis [J].
Lapolla, A ;
Flamini, R ;
Lupo, A ;
Aricò, NC ;
Rugiu, C ;
Reitano, R ;
Tubaro, M ;
Ragazzi, E ;
Seraglia, R ;
Traldi, P .
MAILLARD REACTION: CHEMISTRY AT THE INTERFACE OF NUTRITION, AGING, AND DISEASE, 2005, 1043 :217-224
[33]   Glyoxal and methylglyoxal levels in diabetic patients: Quantitative determination by a new GC/MS method [J].
Lapolla, A ;
Flamini, R ;
Vedova, AD ;
Senesi, A ;
Reitano, R ;
Fedele, D ;
Basso, E ;
Seraglia, R ;
Traldi, P .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (09) :1166-1173
[34]   OXIDATIVELY MODIFIED HUMAN LOW-DENSITY-LIPOPROTEIN STIMULATES LEUKOCYTE ADHERENCE TO THE MICROVASCULAR ENDOTHELIUM INVIVO [J].
LEHR, HA ;
HUBNER, C ;
NOLTE, D ;
FINCKH, B ;
BEISIEGEL, U ;
KOHLSCHUTTER, A ;
MESSMER, K .
RESEARCH IN EXPERIMENTAL MEDICINE, 1991, 191 (02) :85-90
[35]  
LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
[36]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[37]  
Lyons TJ, 1997, DIABETES REV, V5, P365
[38]   EFFECT OF GLYCATION ON THE PROPERTIES OF LIPOPROTEIN(A) [J].
MAKINO, K ;
FURBEE, JW ;
SCANU, AM ;
FLESS, GM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (03) :385-391
[39]   Preferential recognition of epitopes on peroxynitrite-modified alpha-2-macroglobulin by circulating autoantibodies in rheumatoid arthritis patients [J].
Malik, Heena Imtiaz ;
Mir, Abdul Rouf ;
Abidi, Minhal ;
Habib, Safia ;
Khan, Fahim Halim ;
Moinuddin .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (07) :1984-1994
[40]   Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls [J].
Mironova, M ;
Virella, G ;
VirellaLowell, I ;
LopesVirella, MF .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 85 (01) :73-82
1234567